Parathyroid Hormone Related Peptide (PTHrP) Test
Blood Sample
Free Home Collection
Digital Smart Report
Recommended for Male/Female
NABL & CAP Certified Labs
Trusted by Leading Doctors & Organizations
About Parathyroid Hormone-related Peptide (PTH-rP) Test
The Parathyroid Hormone-related Peptide (PTH-rP) Test measures the levels of PTH-rP, a protein that plays a crucial role in calcium regulation and bone metabolism. Although it functions similarly to parathyroid hormone (PTH), PTH-rP is primarily associated with humoral hypercalcemia of malignancy (HHM), a condition where tumors secrete excess PTH-rP, leading to elevated blood calcium levels (hypercalcemia).
PTH-rP is normally involved in various physiological processes, including:
- Fetal development, where it regulates calcium transport across the placenta.
- Lactation, where it helps mobilize calcium for breast milk production.
- Bone remodeling, by influencing osteoblast and osteoclast activity.
However, in cancerous conditions, excessive PTH-rP production can lead to severe hypercalcemia, kidney damage, and neurological symptoms. Common malignancies associated with high PTH-rP levels include lung cancer, breast cancer, renal cell carcinoma, and multiple myeloma. Differentiating between malignancy-induced hypercalcemia and primary hyperparathyroidism is critical for proper diagnosis and treatment.
What is the PTH-rP Test Used For?
This test is used to:
- Diagnose humoral hypercalcemia of malignancy (HHM).
- Differentiate between primary hyperparathyroidism and malignancy-related hypercalcemia.
- Monitor calcium-related disorders in cancer patients.
- Assess abnormal bone metabolism or paraneoplastic syndromes.
Symptoms of Abnormal Parathyroid Hormone-related Peptide Levels
Early-stage cervical cancer often has no symptoms, making regular Pap smears and HPV testing essential. As the disease progresses, symptoms may include
-
Unusual vaginal bleeding- Bleeding between periods, Postmenopausal bleeding, Bleeding after intercourse, douching, or pelvic exams
-
Abnormal vaginal discharge- Watery, bloody, or foul-smelling discharge, Heavy or persistent discharge
-
Pelvic pain or discomfort- Pain during intercourse, Chronic pelvic or lower back pain
-
Leg swelling (lymphatic obstruction)
-
Difficulty urinating or blood in urine
-
Unexplained weight loss or fatigue
Preparation for the test :
Fasting is not required. A blood sample is drawn from a vein for analysis. Avoid calcium supplements or vitamin D before testing, as they can affect calcium metabolism. Inform your doctor about medications that influence calcium levels, such as diuretics or bisphosphonates.
Interpretation of Results
- Normal (Negative for intraepithelial lesion or malignancy)- No abnormal cells detected.
- Atypical Squamous Cells of Undetermined Significance (ASC-US) or Low-Grade Squamous Intraepithelial Lesion (LSIL)- Mild abnormality, often caused by HPV; may require follow-up testing.
- High-Grade Squamous Intraepithelial Lesion (HSIL) or Atypical Glandular Cells (AGC)- Requires further testing, such as colposcopy or biopsy, to rule out precancer or cancer.
- Positive for malignancy- Suggests cervical cancer; further evaluation is necessary.
FAQs on Parathyroid Hormone-related Peptide (PTH-rP) Test
Every 3 years for women aged 21-29.
Every 3-5 years for women aged 30-65, depending on HPV co-testing.
No, but an HPV test may be done alongside a PAP smear for high-risk HPV strains.
While unlikely, it’s possible; regular screenings are important for early detection.
It may cause mild discomfort, but it is generally not painful and lasts only a few minutes.
Your doctor may recommend repeat testing, HPV testing, or a colposcopy with biopsy.
Parathyroid Hormone Related Peptide (PTHrP) Test
